We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acute Pain and Inflammation After Surgery (Knemikro01)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00774540
First Posted: October 17, 2008
Last Update Posted: April 23, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Leiv Arne Rosseland, Oslo University Hospital
  Purpose

The purpose of this study is

  1. to observe acute pain after surgery and measure the natural course of inflammatory mediators
  2. study pain relieving effects and local anti-inflammatory effects of systemically administered ketorolac

Condition Intervention Phase
Knee Injuries Drug: 1 Ketorolac intraarticular Drug: Placebo Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Acute Pain and Role of Ketolorac in Inflammatory Mediators After Knee Arthroscopy Evaluated by Microdialysis

Resource links provided by NLM:


Further study details as provided by Leiv Arne Rosseland, Oslo University Hospital:

Primary Outcome Measures:
  • Pain relief local anti-flammatory effects [ Time Frame: 2 h ]

Secondary Outcome Measures:
  • Rescue analgesic consumption [ Time Frame: 2 h ]

Enrollment: 40
Study Start Date: August 2008
Study Completion Date: December 2014
Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Ketorolac
Drug: 1 Ketorolac intraarticular
Ketorolac intraarticular 5 mg
Other Names:
  • Ketorolac
  • Saline
Placebo Comparator: 2
saline
Drug: Placebo
Saline

Detailed Description:
Randomizized controlled trial
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Day case surgical patients above 18 years old
  • Non pregnant

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00774540


Locations
Norway
Oslo University Hospital, Division of Emergencies and Critical Care
Oslo, Norway, 0242
Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Leiv Arne Rosseland Oslo University Hospital
  More Information

Responsible Party: Leiv Arne Rosseland, Professor, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT00774540     History of Changes
Other Study ID Numbers: Knemikro01
S-04342
First Submitted: October 16, 2008
First Posted: October 17, 2008
Last Update Posted: April 23, 2015
Last Verified: April 2015

Keywords provided by Leiv Arne Rosseland, Oslo University Hospital:
Acute pain
Inflammatory pain
Inflammatory mediators
Pain relief
Microdialysis

Additional relevant MeSH terms:
Acute Pain
Knee Injuries
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Leg Injuries
Wounds and Injuries
Ketorolac
Ketorolac Tromethamine
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action